Looking for PBMCs, plasma, or serum for your biomarker study? Join us and our colleagues at Crown Bioscience next week at the 14th World Clinical Biomarkers & CDx Summit! Schedule a meeting with our experts in advance or stop by booth 36 to learn how we can be your comprehensive partner for your biomarker solutions and learn more about our products and services. 📅Date: September 3 – 6, 2024 📍Location: The Westin Boston Seaport District, Boston, MA ➡️https://hubs.la/Q02MKyn50 #WorldCDX #Biomarkers #LiquidBiopsy #PrecisionMedicine
Indivumed Services’ Post
More Relevant Posts
-
Aiming to accelerate disease based scientific research and drug development through working with innovative technologies.
We are proud to sponsor Biomarkers EU in Basel. Clinical and translational autoantibody biomarkers from blood samples can unlock understanding of disease mechanisms, patient response (including irAEs) and patient endotyping. It will be great to meet with people interested in measuring novel biomarkers for immune mediated inflammatory diseases, immuno-oncology and neurodegenerative diseases. #BiomarkersEU24 #proteomics #biomarkers #autoimmune #neurosciences #immunooncology
Learn more about Sengenics, a functional proteomics company utilising their patented KREX protein folding technology to identify autoantibody biomarker signatures for predicting drug responses, patient stratification, and developing companion diagnostics. Check them out at Biomarkers Europe 2024! ✨ ▶️ Find event details here: https://hubs.la/Q02tzV_k0 #OGBiomarkers #BiomarkersEU24 #ProteinArrays #CompanionDiagnostics
-
-
Biomarkers are changing the future of clinical research! From personalized treatments to using AI for faster discoveries, advanced biomarkers are shaping the way we understand and treat diseases. As we dive into trends like liquid biopsies and digital biomarkers, the potential to improve patient outcomes has never been greater. At Abiogenesis Clinpharm, we’re staying ahead of the curve, using the latest innovations to power successful clinical trials. Partner with us to bring your research to the next level! 🚀 #Biomarkers #ClinicalResearch #AIinHealthcare #Innovation #Biomarkers #Abiogenesisclinpharm #Clinicatrials #Pharma #cro #clinicalresearchorganization
-
In this webinar, learn how a novel immunoassay kit and multiplex platform streamlines biomarker screening, saving researchers time and preserving their precious samples. #AD Register today: https://ow.ly/qFJH50REU7o
-
EIP is a Key meeting to stay up on current immunogenicity analysis techniques and guidance.
Our team is onsite at EIP European Immunogenicity Platform in Lisbon, Portugal. Visit our booth to learn from our experts how our bioanalytical capabilities can support your next Immunogenicity, PK and Biomarker assay project. Be sure to attend Principal Investigator Matthias Reichel presentation on phase-appropriate implementation of a domain specificity strategy for immunogenicity characterization and Scientific Officer Robert Nelson, PhD presentation on IVDR and its impact on clinical immunogenicity assay development. Both presentations take place on 23 April. Learn more about our immunogenicity services here: https://bit.ly/4b6hbHY #immunogenicity #biotherapeutics #biopharma #InnovationInScience
-
-
In this webinar brought to you by Merck, learn how a novel immunoassay kit and multiplex platform streamlines biomarker screening, saving researchers time and preserving their precious samples. #AD Register today: https://ow.ly/Rs5F50RETs2
Painless Protein Profiling Through Advanced Multiplexing
the-scientist.com
-
Looking forward to sharing and learning more (including from our very own Jeffrey G.) about how to improve access to precision oncology at the World CB and CDx conference in Boston this week. Scalable decentralization is the key #genomics4all.
Biofidelity is honored to host a panel discussion at the 14th World Clinical Biomarkers & Companion Diagnostics Summit Hanson Wade Group September 3-6th in Boston, MA. Dr. Jeffrey Gregg, Biofidelity's VP of Medical Affairs, will moderate a panel featuring Kara O'Brien, Executive Director, Global Precision Diagnostics, Market & Ecosystem Shaping Novartis and Zheng Feng, Director & Head, Clinical Genomics Clinical Biomarker Technologies EMD Serono, Inc. Join their discussion on Friday, Sept 6th at 11:35am (Track C)! https://hubs.ly/Q02Mc80b0 #biomarkers #decentralization
-
-
While I didn't make it to #ASCO24 this year, I did take a quick look at some of the #Radiomics abstracts! 40 of this year's ASCO abstracts mention "radiomic." Of these, 6 explore the use of radiomic features for predicting expression of known biomarkers, while most others explored radiomic features alone for various use cases. Also, there are a number of #pharma co-authored abstracts, which tends to be a decent stamp of approval for new techs. Comment below if there are any surprises! Also, what companies should I keep my eye on? 👀 #PrecisionOncology DeciBio AstraZeneca Bristol Myers Squibb Immunocore iOnctura Onc.AI Labcorp Pfizer Picture Health Quibim Raidium SimBioSys, Inc.
-
-
Well done DeciBio for considering #radiomics into your Precision Medicine analysis, a perfect complement to genomics, assessing phenotype and tissue heterogeneity. The best is yet to come!
While I didn't make it to #ASCO24 this year, I did take a quick look at some of the #Radiomics abstracts! 40 of this year's ASCO abstracts mention "radiomic." Of these, 6 explore the use of radiomic features for predicting expression of known biomarkers, while most others explored radiomic features alone for various use cases. Also, there are a number of #pharma co-authored abstracts, which tends to be a decent stamp of approval for new techs. Comment below if there are any surprises! Also, what companies should I keep my eye on? 👀 #PrecisionOncology DeciBio AstraZeneca Bristol Myers Squibb Immunocore iOnctura Onc.AI Labcorp Pfizer Picture Health Quibim Raidium SimBioSys, Inc.
-
-
🌟 Soft Cell Labs and Pharmacogenomics! 🌟 Soft Cell Laboratories has validated our new Pharmacogenomics (PGx) genotyping assay. This innovative tool is transforming the landscape of personalized medicine by enabling clinicians to offer targeted therapeutics tailored to each individual patient. Not only does this assay enhance treatment efficacy, but it also promotes cost-effectiveness and efficiency in clinical practice. This breakthrough represents a significant step forward in providing precision medicine solutions that align with the unique needs of every patient. Explore how our PGx genotyping assay can optimize patient care and improve outcomes in your practice. #SoftCellLaboratories #Pharmacogenomics #PersonalizedMedicine #Healthcare #Innovation #ClinicalExcellence Check out this article: https://lnkd.in/gv-e9CRw
-
-
🔬 Exciting news for biomarker and companion diagnostics enthusiasts - Here is the 2nd Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference - East Coast Edition! 📅 Mark your calendars for June 20 - 21, 2024, in Boston, Massachusetts, USA. Register Now: https://bit.ly/3vt6ccB 🏙️ Organized by MarketsandMarkets Conferences, this in-person event offers insights into turning biomarkers into companion diagnostics. 🧬 #Biomarkers #BostonConference #eMedEvents
-
